5 ASA Synthesis

This lab could have contained errors. The errors could have happened when performing the lab. Some of the possible errors in this lab are:

3. Spicy Food! This one bothers a lot of Crohn’s patients but I personally can eat most mild foods in moderation and be fine.

Are there any contraindications for this drug? Hypersensitivity, cross-sensitivity with other NSAID’s such as aspirin, history of allergic reactions, asthma, advanced renal disease, hepatic dysfunctions, perioperative pain.

After putting the CH2Cl2 to a beaker containing the drying agent anhydrous sodium sulfate, a sticky white solid was recovered.

This 72-year-old claimant sustained a work-related injury on 04/22/07. The claimant continues to have discomfort in the right thigh, buttock area, and lumbar spine. She has a pain rating of 2-7/10. She takes Voltaren more regularly and the Tylenol only when the pain is greater. It was noted that she has been taking these medications for years with benefit. The claimant’s pain has decreased and the claimant is able to complete activities of daily living with the use of medications. However, this medication is listed as a “Non-Preferred” drug in the formulary. There is no documentation of failed trials of “Preferred” drugs and documentation indicating that this medication is more beneficial to the claimant than a “Non-Preferred”

DS is a 57-year-old white female whit a history of diverticulitis who presents to the clinic for an evaluation of abdominal pain. She stated that she began experiencing left lower quadrant pain last night that worsened through the night and into this morning. The pain is described as dull, occasionally cramping, rated 7/10 in severity. The patient also stated that this pain is similar to previous episodes of diverticulitis. The patient stated that she took Gas-X this morning with little relief. She was able to move her bowels yesterday and this morning, both reportedly normal. The patient denied any fever, chills, chest pain, shortness of breath, nausea, vomiting, diarrhea, melena, hematochezia, or any other symptoms. At this time, there were

B.S. is an 81 year old Caucasian female presenting with abdominal pain, diarrhea, nausea and vomiting in the emergency room on February 3, 2013. B.S. has a history of glaucoma, hypothyroidism, degenerative arthritis and diverticulosis. She has allergies to iodine and vicodin. B.S. is admitted for diverticulitis with possible partial bowel obstruction and hydronephrosis. B.S. was admitted on February 3, 2013 here at Verdugo Hills Hospital.

b. if people with ulcer takes ASA, the ulcer would be aggravated, because ASA can cause further worsening of the ulcer and cause bleeding, and more pain and irritation.

There is a selection of appropriate interventions taken when treating Crohn’s disease which will vary for different patients however there is no cure. Early treatment of the disease has proven to be effective through trials with immunomodulators and anti-TNF agents. Anti-inflammatory drugs or antibiotics are helpful in treating colon and minor bowel inflammation. 5-aminosalicylic acid derivative agents such as sulfasalazine and balsalazide are used to treat mild and moderate Crohn’s disease and to maintain remission.

Attending to her ulcerative colites, she was initially treated with messalazine 3g/day without response and subsequently with prednisolone 20 to 40 mg/day and azathioprine 100mg/day (2mg/kg/day). Other medications included calcium and vitamin D. Nevertheless she presented several acute episodes of ulcerative colitis and was started on anti-TNFα, Infliximab (IFX) intravenously administered at a standard dose of 5 mg/Kg at week 0, 2, 6 and then every 8 weeks. After 12 months of anti-TNF α therapy she presented complete pain relief. Radiological evolution, which is difficult to analyze due to irregular hyperostosis, showed no evidence of disease progression (Figure 1B). Bone densitometry (dual-energy X-ray absorptiometry, DEXA) showed lumbar osteopenia (L1-L4; T score -1.8 and Z score -1.7) and increased bone density of femur neck and forearm (T score -3.6 and 6.7). These results indicated an increase in bone density at the lumbar level and decrease in density in femur neck, to values found 10 years before anti-TNF alfa therapy. Also, for bone scintigraphy lower radionuclide uptake was observed after treatment. (Figure

Assessent criteria: Remission: <2.6 points; significant response: reduction ≥1.2 points; continued improvement: reduction <1.2 points, and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with AS (remission: <2.0; significant response: reduction ≥2.0 points; continued improvement: reduction <2.0 points. CT-P13 demonstrated comparable effectiveness to its RP. All patients who switched to the biosimilar maintained or improved their clinical response, including two who remained in remission and three who moved into remission. Switching from the RP to CT-P13 did not affect the safety or effectiveness of treatment in patients with different inflammatory diseases in this study.

Medications that can cause interactions include anticoagulants, probenecid, bisphosphonates, angiotensin-converting enzyme (ACE) inhibitors, anticoagulants (Warfarin), antiplatelet medicines (Clopidogrel), aspirin, corticosteroids (Prednisone), heparin, other NSAIDs (Ibuprofen), Rivaroxaban, or Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine) due to the risk of stomach bleeding may be increased. Bisphosphonates (Alendronate), Cyclosporine, Hydantoins (Phenytoin), Lithium, Methotrexate, Quinolones (Ciprofloxacin), Sulfonamides (Sulfamethoxazole), and Sulfonylureas (Glipizide) side effects may be increased by Naproxen. The effectiveness of Angiotensin-converting enzyme (ACE) inhibitors (Enalapril), Beta-blockers (Propranolol), or diuretics (Furosemide, Hydrochlorothiazide) may be decreased by Naproxen (Lexi-Comp,

Adverse reactions to this medication are migraine, speech disorders, rhinitis, sinusitis, hyperglycemia, elevated liver function, elevated serum creatinine level, pancytopenia, bronchitis, dyspnea, toxic epidermal necrolysis, anaphylaxis, elevated creatine kinase, generalized pain, and infection. Nursing considerations with this medication is to have the patient swallow the whole tablet and not to chew. Watch for aspiration while watching the patient take the medication. Educate the patient about the medication and inform them to notify a physician if bleeding

Riblets and tripwires are widely explored and documented structures that have a huge potential for use in drag reduction technology. Passive strategies for drag reduction in air and underwater vehicles, such as airplanes and submarines, are increasingly being investigated as they reduce the cost of operation of the vehicle by increasing its speed and efficiency. This essay discusses riblets and tripwires, and their use in drag reduction technology. Their optimal specifications, mechanism of functioning and potential applications for drag reduction over underwater aerofoils have also been dealt with.

Millions of parents before the school year go out and get their children vaccinated, to be safe and ready for the upcoming school year. There are several different types of vaccinations for different diseases. Some different vaccinations that protect your child are the measles vaccination, flu shot, diphtheria vaccination, tetanus shot, all 3 hepatitis vaccinations, and many more. The first vaccine was created on May 14, 1796 with smaller pox. One of the first vaccines to totally wipe out a contagious disease was for the HIB disease which could lead to infection in the brain and spinal cord and inflammation in the voice box, and infection in joints, blood, bones, and the pericardium which covers your heart. Vaccine was licensed in 1985, which eliminated the disease in the developing world. Vaccinations should be required for all children, because they will be less likely to get disease, it is covered by insurance, and if they aren’t vaccinated it could put public health in danger.